The Global Pharmaceutical Lipids Market Size was valued at USD 4,198 Million in 2021 and is predicted to be worth USD 6,617 Million by 2030, with a CAGR of 5.4% from 2022 to 2030.

Lipids are widely used as fillers, binders, lubricants, solubilizers, emulsifiers, and emollients for delivery of drugs. The most important function of lipids is to play as cell membrane transport agents in cell membrane.

Report Coverage

Market	Pharmaceutical Lipids Market
Market Size 2021	USD 4,198 Million
Market Forecast 2030	USD 6,617 Million
CAGR During 2022 - 2030	5.4%
Analysis Period	2018 - 2030
Base Year	2021
Forecast Data	2022 - 2030
Segments Covered	By Product, By Form, By Source, By Application, And By Geography
Regional Scope	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Key Companies Profiled	ABITEC Corporation, Nippon Oil & Fats Corporation, Lipoid GmbH, Nippon Fine Chemical Co. Ltd., BASF SE, Dishman Group, Cayman Chemical Company, CordenPharma, Croda International Plc, Gattefossé, IOI Oleo GmbH, Merck KGaA, Stepan Company, and Evonik Industries AG
Report Coverage	Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis
Customization Scope	10 hrs of free customization and expert consultation

Pharmaceutical Lipids Market Dynamics

Pharmaceutical sector across the globe is witnessing rapid growth. With the rising investment in the sector and high R&D activities taking place across developed and developing countries for new drug development. The industry is observing high growth. According to the Pharmaceutical Research and Manufacturers Association (PhRMA), U.S. firms conduct over half the world's R&D in pharmaceuticals US$ 75 Bn and hold the intellectual property rights on most new medicines. Lipids are widely used as fillers, binders, lubricants, solubilizers, emulsifiers, and emollients for delivery of drugs. Flourishing cosmetic sector across the globe and high demand from cosmetic sector for lipid solutions as ingredients are major factors expected to drive the growth of global pharmaceutical lipids market. Major players are investing high for product development activities their approach towards enhancing the business through product launch and acquisition is expected to augment the growth of global pharmaceutical lipids market.

Covid-19 pandemic on its peak and high investment form public and private players for development of vaccines is resulting in players approach towards ramping up the production of lipids to care the growing needs. This is expected to impact the growth of target market. In 2021, MilliporeSigma, a global manufacturer of lipids increased its production capacity by 50 times, helping biomanufacturers bring lifesaving therapies to patients faster. MilliporeSigma is collaborating with more than 50 companies to support their efforts in the development and production of Covid-19 vaccines and treatments, providing custom lipids, as well as other critical raw materials, processing equipment and services used in mRNA drugs and vaccines manufacturing. Factors such as high cost associated to R&D activities and stringent government regulations related to product approval are expected to hamper the growth of global pharmaceutical lipids market. In addition, lack of developed infrastructure in developing countries is expected to limit the R&D activities further challenging the growth of target market. However, increasing government spending on development of healthcare sector and introduction of new products are factors expected to create new opportunities for players operating in the pharmaceutical lipids market over the forecast period. In addition, increasing partnership and agreements between regional and international players is expected to support the revenue transaction of the target market.

Pharmaceutical Lipids Market Segmentation

The global pharmaceutical lipids market is segmented into product, form, source and application. The product segment is divided into triglycerides, phospholipids, sphingolipids, cholesterol, fatty acids, and others. Among product the triglycerides segment is expected to account for major revenue share in the global pharmaceutical lipids market. The application segment is divided into conventional lipid-based drug delivery systems, self-emulsifying drug delivery systems, self-microemulsifying drug delivery systems, liposomes, solid lipid nanoparticles, nanostructured lipid carriers, and others. The form segment is further segmented into liquid pharmaceutical lipids, semi-solid pharmaceutical lipids, and solid pharmaceutical lipids. The source segment is categorized into synthetic pharmaceutical lipids, semi-synthetic pharmaceutical lipids, and natural pharmaceutical lipids.

Market by Product

• Triglycerides
• Phospholipids
• Sphingolipids
• Cholesterol
• Fatty Acids
• Others

Market by Form

• Liquid Pharmaceutical Lipids
• Semi-solid Pharmaceutical Lipids
• Solid Pharmaceutical Lipids

Market by Source

• Synthetic Pharmaceutical Lipids
• Semi-synthetic Pharmaceutical Lipids
• Natural Pharmaceutical Lipids

Market by Application

• Conventional Lipid-based Drug Delivery Systems
• Self-Emulsifying Drug Delivery Systems
• Self-Microemulsifying Drug Delivery Systems
• Liposomes
• Solid Lipid Nanoparticles
• Nanostructured Lipid Carriers
• Others

Pharmaceutical Lipids Market Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Latin America

• Mexico
• Brazil
• Rest of Latin America

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

The Middle East & Africa (MEA)

• Gulf Cooperation Council (GCC)
• South Africa
• Rest of the Middle East & Africa